Compare EZPW & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZPW | SDGR |
|---|---|---|
| Founded | 1989 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 1991 | 2020 |
| Metric | EZPW | SDGR |
|---|---|---|
| Price | $19.84 | $18.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $21.00 | ★ $26.25 |
| AVG Volume (30 Days) | ★ 1.4M | 819.3K |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.89 | N/A |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $1,274,280,000.00 | $256,951,000.00 |
| Revenue This Year | $11.91 | $23.69 |
| Revenue Next Year | $7.78 | $20.46 |
| P/E Ratio | $14.25 | ★ N/A |
| Revenue Growth | 9.70 | ★ 32.90 |
| 52 Week Low | $11.60 | $15.99 |
| 52 Week High | $21.49 | $28.47 |
| Indicator | EZPW | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 52.78 | 51.45 |
| Support Level | $19.09 | $17.02 |
| Resistance Level | $20.55 | $19.44 |
| Average True Range (ATR) | 0.61 | 0.79 |
| MACD | -0.12 | 0.15 |
| Stochastic Oscillator | 30.83 | 52.48 |
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.